🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05725096
Recruiting Not applicable

Role of Coronary CTA on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population

NCT05725096 · tracked via the Priya Life Science China tracker
Sponsor
Zhang longjiang,MD
Phase
Not applicable
Started
2023-06-28
Last updated
2024-11-26

Condition(s) studied

StatinCardiovascular Risk FactorsPrimary PreventionAdherence, Medication

Investigational drug(s) / intervention(s)

Coronary Computed Tomography AngiographyTraditional cardiovascular risk stratification

Coronary Computed Tomography Angiography: Intervention strategies according to CCTA results

Traditional cardiovascular risk stratification: Intervention strategies according to traditional cardiovascular risk stratification based on Chinese guidelines for lipid management (2023)

Study summary

The primary objective of this study is to determine whether coronary computed tomography angiography (CCTA) -based coronary heart disease(CHD) prevention strategy improves lipid-lowering treatment and cardiovascular risk factor control compared with traditional CHD prevention strategy, guided by a cardiovascular risk score.

Eligibility

Sex
ALL
Min age
40 Years
Max age
69 Years
Healthy volunteers
No
Inclusion Criteria: 1. Nanjing residents who have no plans to leave in the next 5 years 2. Aged from 40 to 69 years 3. Free of any known clinically cardiovascular disease Able to comprehend and sign an informed consent form Exclusion Criteria: 1. Serious liver dysfunction, defined as AST or ALT \> 3 times the normal upper limit 2. Chronic kidney disease (CKD) \> stage 4, defined as eGFR \< 30 ml/min/1.73 m2 3. Prior CCTA or invasive coronary angiography within the last 5 years 4. Any contraindications for CCTA 5. Previous use of statin or non-statin lipid-lowering medication (such as ezetimibe, PCSK9 inhibitor and XueZhiKang) 6. Life expectancy \< 3 years 7. Other reasons the researcher deems inappropriate to attend

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Research Institute Of Medical Imaging Jinling Hospital Nanjing Jiangsu Recruiting

More Zhang longjiang,MD trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05725096 on ClinicalTrials.gov ↗ ← All trials in China